Suppr超能文献

用于细胞功能障碍的癌症蛋白质组学:见解与趋势

Cancer Proteomics for Cellular Dysfunction: Insights and Trends.

作者信息

Rani Anjna, Devi Singh Veena, Mazumder Rupa, Dua Kamal

机构信息

Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, UP-201306, India.

Shri Rawatpura Sarkar College of Pharmacy, Shri Rawatpura Sarkar University, Dhaneli, Raipur, CG-492015, India.

出版信息

Curr Pharm Des. 2023;29(9):697-712. doi: 10.2174/1381612829666230316110932.

Abstract

BACKGROUND

Cancer is an ailment with having a very low survival rate globally. Poor cancer prognosis is primarily caused by the fact that people are found to have the disease when it is already well advanced. The goal of this study is to compile information on new avenues of investigation into biomarkers that may facilitate the routine detection of cancer. Proteomic analysis has recently developed into a crucial technique for cancer biology research, working in tandem with genomic analysis. Mass spectrometry techniques are one of several proteome analysis techniques that allow for the highly precise quantitative and qualitative recognition of hundreds of proteins in small quantities from various biological materials. These findings might soon serve as the foundation for better cancer diagnostic techniques.

METHODS

An exhaustive literature survey has been conducted using electronic databases such as Google Scholar, Science Direct, and PubMed with keywords of proteomics, applications of proteomics, the technology of proteomics, biomarkers, and patents related to biomarkers.

RESULT

Studies reported till 2021 focusing on cancer proteomics and the related patents have been included in the present review to obtain concrete findings, highlighting the applications of proteomics in cancer.

CONCLUSION

The present review aims to present the overview and insights into cancer proteomics, recent breakthroughs in proteomics techniques, and applications of proteomics with technological advancements, ranging from searching biomarkers to the characterization of molecular pathways, though the entire process is still in its infancy.

摘要

背景

癌症是一种在全球范围内生存率极低的疾病。癌症预后不佳主要是因为人们在疾病已经发展到晚期时才被发现患病。本研究的目的是收集有关生物标志物新研究途径的信息,这些生物标志物可能有助于癌症的常规检测。蛋白质组学分析最近已发展成为癌症生物学研究的一项关键技术,与基因组分析协同发挥作用。质谱技术是多种蛋白质组分析技术之一,它能够从各种生物材料中对少量数百种蛋白质进行高精度的定量和定性识别。这些发现可能很快会成为更好的癌症诊断技术的基础。

方法

使用谷歌学术、科学Direct和PubMed等电子数据库进行了详尽的文献调查,关键词为蛋白质组学、蛋白质组学的应用、蛋白质组学技术、生物标志物以及与生物标志物相关的专利。

结果

本综述纳入了截至2021年报道的关注癌症蛋白质组学及相关专利的研究,以获得具体发现,突出蛋白质组学在癌症中的应用。

结论

本综述旨在概述和深入探讨癌症蛋白质组学、蛋白质组学技术的最新突破以及随着技术进步蛋白质组学的应用,从寻找生物标志物到分子途径的表征,尽管整个过程仍处于起步阶段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验